Robert L. Hudkins
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Mast cells and histamine, Phenothiazines and Benzothiazines Synthesis and Activities, Angiogenesis and VEGF in Cancer, Bioactive Compounds and Antitumor Agents
Most-Cited Works
- → Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery(2011)433 cited
- CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.(2003)
- → Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a Derivatives(1997)119 cited
- → Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors(2016)113 cited
- → The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity(2007)110 cited
- → Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells(2005)105 cited
- → 2 Discovery of Cep-1347/Kt-7515, an Inhibitor of the Jnk/Sapk Pathway for the Treatment of Neurodegenerative Diseases(2002)98 cited
- → Synthesis Of 2-Aryl- and 2-Vinyl-1H-indoles via Palladium-Catalyzed Cross-Coupling of Aryl and Vinyl Halides with 1-Carboxy-2-(tributylstannyl)indole(1995)95 cited
- → Mixed lineage kinase activity of indolocarbazole analogues(2002)94 cited
- → Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases(2010)74 cited